Customising informed consent procedures for people with schizophrenia in India
Sudipto Chatterjee, Berit Kieselbach, Smita Naik, Shuba Kumar, Sujit John, Madhumitha Balaji, Mirja Koschorke, Hamid Dabholkar, Mathew Varghese, Vikram Patel, Graham Thornicroft, Rangaswamy Thara
Social Psychiatry and Psychiatric Epidemiology | SPRINGER HEIDELBERG | Published : 2015
Awarded by National Institute for Health Research
The authors gratefully acknowledge the Wellcome Trust for having provided the academic grant for conducting the COPSI trial. The generous participation of people with schizophrenia and their family is greatly appreciated, as without their support, the study would not have been possible. The authors are also grateful to all the COPSI staff members-Dr. Vikram Arunachalam and Dr. Yamani Kanappan at Chennai, Minakshi Pisal, Uday Chavhan and Prashant Potdar at Satara and Anthony Lobo, Basvaraj Katti, Swamini Kakodkar, Arthi Rajan and Fatima Gomes at Goa, who conducted the interviews across the sites and to Nupur Lala who helped with the initial data management framework. We would also like to specifically thank all the collaborating Psychiatrists in the COPSI study-Dr. T. C. Ramesh Kumar, Dr. R. Padmavati, Dr. H. Dabholkar, Dr. P. Dabholkar, Dr. A. Chavan, Dr. R. Deshpande, Dr. R. Hegde, Dr. P. Pai Kakode, Dr. M. Chagas Silva and Dr. P. Castelino, for their role in coordinating various aspects of the study at the three sites. We are also grateful to the IRB's of Sangath and SCARF for their valuable comments in designing the consent procedure. The ethics committees at the KCL and the LSHTM also provided a critical and independent overview of the ethical aspects of the trial which we benefitted from. Finally, we wish to thank the members of the Trial Monitoring Committee-Professor Mohan Isaac (Chairperson), Baljeet Ahluwalia, Professor P. Chandra, Professor R. Raguram and Additional Professor K. Thennarasu for their active and valuable contributions in developing and monitoring the procedure.